European Medicines Agency recommends approval of Daklinza in chronic hepatitis C

View source ↗

Summary

The European Medicines Agency recommends approval of Daklinza for use in chronic hepatitis C, indicating regulatory endorsement for its indication in treating c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)